CD44 and cancer: Disorders in CD44 function or expression lead to a wide range of abnormalities, including impaired leukocyte migration, chronic inflammation, excessive activation of fibroblasts and myofibroblasts, pathological tissue fibrosis, and increased invasiveness of cancer cells.